Reductive stress impairs myoblasts mitochondrial function and triggers mitochondrial hormesis

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1853, Issue 7, 2015, Pages 1574-1585

  Singh, François ^a,b,c   Charles, Anne Laure ^a   Schlagowski, Anna Isabel ^a,b   Bouitbir, Jamal ^c   Bonifacio, Annalisa ^c   Piquard, François ^a   Krähenbühl, Stephan ^c   Geny, Bernard ^a,b   Zoll, Joffrey ^a,b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b HÔPITAL CIVIL   (France)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Apoptosis; Mitohormesis; Myoblast; N acetylcysteine; Reductive stress; Statin

Indexed keywords

ACETYLCYSTEINE; ATORVASTATIN; GLUTATHIONE; HYDROGEN PEROXIDE; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROTECTIVE AGENT;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BIOGENESIS; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFECT; DRUG EXPOSURE; EXPOSURE VARIABLE; HORMESIS; IN VITRO STUDY; MITOCHONDRIAL RESPIRATION; MYOBLAST; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; ANIMAL; CELL PROTECTION; CELL RESPIRATION; CELL SURVIVAL; DRUG EFFECTS; METABOLISM; MITOCHONDRIAL DYNAMICS; MITOCHONDRION; OXIDATION REDUCTION REACTION; PHYSIOLOGICAL STRESS; TIME;

ACETYLCYSTEINE; ANIMALS; CELL RESPIRATION; CELL SURVIVAL; CYTOPROTECTION; HORMESIS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MITOCHONDRIA; MITOCHONDRIAL TURNOVER; MYOBLASTS; OXIDATION-REDUCTION; PROTECTIVE AGENTS; RATS; REACTIVE OXYGEN SPECIES; STRESS, PHYSIOLOGICAL; TIME FACTORS;

EID: 84926500647     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2015.03.006     Document Type: Article

References (59)

1. Otrocka-Domagała I. Sensitivity of skeletal muscle to pro-apoptotic factors. Pol. J. Vet. Sci. 2011, 14:683-694.
2. Brewer A.C., Mustafi S.B., Murray T.V.A., Rajasekaran N.S., Benjamin I.J. Reductive stress linked to small HSPs, G6PD, and Nrf2 pathways in heart disease. Antioxid. Redox Signal. 2013, 18:1114-1127.
3. Allen R., Tresini M. Oxidative stress and gene regulation. Free Radic. Biol. Med. 2000, 28:463-499.
4. Bouitbir J., Charles A.L., Echaniz-Laguna A., Kindo M., Daussin F., Auwerx J., Piquard F., Geny B., Zoll J. Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a "mitohormesis" mechanism involving reactive oxygen species and PGC-1. Eur. Heart J. 2012, 33:1397-1407.
5. Gems D., Partridge L. Stress-response hormesis and aging: "that which does not kill us makes us stronger". Cell Metab. 2008, 7:200-203.
6. Ristow M., Zarse K. How increased oxidative stress promotes longevity and metabolic health: the concept of mitochondrial hormesis (mitohormesis). Exp. Gerontol. 2010, 45:410-418.
7. Sano M., Fukuda K. Activation of mitochondrial biogenesis by hormesis. Circ. Res. 2008, 103:1191-1193.
8. Schulz T.J., Zarse K., Voigt A., Urban N., Birringer M., Ristow M. Glucose restriction extends Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress. Cell Metab. 2007, 6:280-293.
9. Tapia P.C. Sublethal mitochondrial stress with an attendant stoichiometric augmentation of reactive oxygen species may precipitate many of the beneficial alterations in cellular physiology produced by caloric restriction, intermittent fasting, exercise and dietary p. Med. Hypotheses 2006, 66:832-843.
10. Woolley J.F., Corcoran A., Groeger G., Landry W.D., Cotter T.G. Redox-regulated growth factor survival signaling. Antioxid. Redox Signal. 2013, 19:1815-1827.
11. Schwartz D.R., Sack M.N. Targeting the mitochondria to augment myocardial protection. Curr. Opin. Pharmacol. 2008, 8:160-165.
12. Cornelius C., Perrotta R., Graziano A., Calabrese E.J., Calabrese V. Stress responses, vitagenes and hormesis as critical determinants in aging and longevity: mitochondria as a "chi". Immun. Ageing 2013, 10:15.
13. Schapira A.H. Mitochondrial diseases. Lancet 2012, 379:1825-1834. (2012/04/10 Ed.).
14. Ventura-Clapier R., Mettauer B., Bigard X. Beneficial effects of endurance training on cardiac and skeletal muscle energy metabolism in heart failure. Cardiovasc. Res. 2007, 73:10-18. (2006/10/19 Ed.).
15. Wilson L., Yang Q., Szustakowski J.D., Gullicksen P.S., Halse R. Pyruvate induces mitochondrial biogenesis by a PGC-1 alpha-independent mechanism. Am. J. Physiol. Cell Physiol. 2007, 292:C1599-C1605.
16. Dumaswala U.J., Zhuo L., Mahajan S., Nair P.N., Shertzer H.G., Dibello P., Jacobsen D.W. Glutathione protects chemokine-scavenging and antioxidative defense functions in human RBCs. Am. J. Physiol. Cell Physiol. 2001, 280:C867-C873.
17. Meister A. On the cycles of glutathione metabolism and transport. Curr. Top. Cell. Regul. 1981, 18:21-58. (1981/01/01 Ed.).
18. Bernstein I.L., Ausdenmoore R.W. Iatrogenic bronchospasm occurring during clinical trials of a new mucolytic agent, acetylcysteine. Dis. Chest 1964, 46:469-473.
19. Sadowska A.M. N-acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease. Ther. Adv. Respir. Dis. 03/01/2012, 6:127-135.
20. Zhang H., Limphong P., Pieper J., Liu Q., Rodesch C.K., Christians E., Benjamin I.J. Glutathione-dependent reductive stress triggers mitochondrial oxidation and cytotoxicity. FASEB J. 2012, 26:1442-1451. (2011/12/29 Ed.).
21. Anderson E.J., Neufer P.D. Type II skeletal myofibers possess unique properties that potentiate mitochondrial H(2)O(2) generation. Am. J. Physiol. Cell Physiol. 2006, 290:C844-C851. (2005/10/28 Ed.).
22. Dikalov S.I., Li W., Mehranpour P., Wang S.S., Zafari A.M. Production of extracellular superoxide by human lymphoblast cell lines: comparison of electron spin resonance techniques and cytochrome C reduction assay. Biochem. Pharmacol. 2007, 73:972-980. (2007/01/16 Ed.).
23. Watanabe M., Houten S.M., Wang L., Moschetta A., Mangelsdorf D.J., Heyman R.A., Moore D.D., Auwerx J. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J. Clin. Invest. 2004, 113:1408-1418. (2004/05/18 Ed.).
24. Liu W., Saint D.A. A new quantitative method of real time reverse transcription polymerase chain reaction assay based on simulation of polymerase chain reaction kinetics. Anal. Biochem. 2002, 302:52-59. (2002/02/16 Ed.).
25. Ramakers C., Ruijter J.M., Deprez R.H., Moorman A.F. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci. Lett. 2003, 339:62-66. (2003/03/06 Ed.).
26. Akerboom T.P., Sies H. Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods Enzymol. 1981, 77:373-382. (1981/01/01 Ed.).
27. Pimentel D., Haeussler D.J., Matsui R., Burgoyne J.R., Cohen R.A., Bachschmid M.M. Regulation of cell physiology and pathology by protein S-glutathionylation: lessons learned from the cardiovascular system. Antioxid. Redox Signal. 2012, 16:524-542. (2011/10/21 Ed.).
28. Barbieri E., Sestili P. Reactive oxygen species in skeletal muscle signaling. J. Signal Transduct. 2012, 982794:2012.
29. Chen Q., Vazquez E.J., Moghaddas S., Hoppel C.L., Lesnefsky E.J. Production of reactive oxygen species by mitochondria: central role of complex III. J. Biol. Chem. 2003, 278:36027-36031.
30. Bouitbir J., Daussin F., Charles A.L., Rasseneur L., Dufour S., Richard R., Piquard F., Geny B., Zoll J. Mitochondria of trained skeletal muscle are protected from deleterious effects of statins. Muscle Nerve 2012, 46:367-373. (2012/08/22 Ed.).
31. Bouitbir J., Charles A.L., Rasseneur L., Dufour S., Piquard F., Geny B., Zoll J. Atorvastatin treatment reduces exercise capacities in rats: involvement of mitochondrial impairments and oxidative stress. J. Appl. Physiol. 2011, 111:1477-1483. (2011/08/20 Ed.).
32. Yuyun X., Jinjun Q., Minfang X., Jing Q., Juan X., Rui M., Li Z., Jing G. Effects of low concentrations of rotenone upon mitohormesis in SH-SY5Y cells. Dose-Response 2013, 11:270-280. (2013/08/10 Ed.).
33. Schmeisser S., Schmeisser K., Weimer S., Groth M., Priebe S., Fazius E., Kuhlow D., Pick D., Einax J.W., Guthke R., Platzer M., Zarse K., Ristow M. Mitochondrial hormesis links low-dose arsenite exposure to lifespan extension. Aging Cell 03/29/2013, 12:508-517.
34. Turrens J.F., Alexandre A., Lehninger A.L. Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria. Arch. Biochem. Biophys. 1985, 237:408-414. (1985/03/01 Ed.).
35. Turrens J.F. Mitochondrial formation of reactive oxygen species. J. Physiol. 2003, 552:335-344. (2003/10/17 Ed.).
36. Menon S.G., Sarsour E.H., Kalen A.L., Venkataraman S., Hitchler M.J., Domann F.E., Oberley L.W., Goswami P.C. Superoxide signaling mediates N-acetyl-L-cysteine-induced G1 arrest: regulatory role of cyclin D1 and manganese superoxide dismutase. Cancer Res. 2007, 67:6392-6399.
37. Lin J., Puigserver P., Donovan J., Tarr P., Spiegelman B.M. Peroxisome proliferator-activated receptor gamma coactivator 1beta (PGC-1beta), a novel PGC-1-related transcription coactivator associated with host cell factor. J. Biol. Chem. 2002, 277:1645-1648.
38. Ljubicic V., Joseph A.M., Saleem A., Uguccioni G., Collu-Marchese M., Lai R.Y., Nguyen L.M., Hood D.A. Transcriptional and post-transcriptional regulation of mitochondrial biogenesis in skeletal muscle: effects of exercise and aging. Biochim. Biophys. Acta 2010, 1800:223-234. (2009/08/18 Ed.).
39. Puigserver P., Spiegelman B.M. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr. Rev. 2003, 24:78-90. (2003/02/18 Ed.).
40. Ventura-Clapier R., Garnier A., Veksler V. Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha. Cardiovasc. Res. 2008, 79. (2008/04/24 Ed.).
41. Gleyzer N., Vercauteren K., Scarpulla R.C. Control of mitochondrial transcription specificity factors (TFB1M and TFB2M) by nuclear respiratory factors (NRF-1 and NRF-2) and PGC-1 family coactivators. Mol. Cell. Biol. 2005, 25:1354-1366. (2005/02/03 Ed.).
42. Scarpulla R.C. Nuclear control of respiratory gene expression in mammalian cells. J. Cell. Biochem. 2006, 97:673-683.
43. Scarpulla R.C. PGC-1-related coactivator, a novel, serum-inducible coactivator of nuclear respiratory factor 1-dependent transcription in mammalian. Cells 2001, 21:3738-3749.
44. Daussin F.N., Rasseneur L., Bouitbir J., Charles A.-L., Dufour S.P., Geny B., Burelle Y., Richard R. Different timing of changes in mitochondrial functions following endurance training. Med. Sci. Sports Exerc. 2012, 44:217-224.
45. Chandel N.S., Budinger G.R. The cellular basis for diverse responses to oxygen. Free Radic. Biol. Med. 2007, 42:165-174. (2006/12/27 Ed.).
46. Guzy R.D., Hoyos B., Robin E., Chen H., Liu L., Mansfield K.D., Simon M.C., Hammerling U., Schumacker P.T. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 2005, 1:401-408. (2005/08/02 Ed.).
47. Kaelin W.G. ROS: really involved in oxygen sensing. Cell Metab. 2005, 1:357-358. (2005/08/02 Ed.).
48. Lee S.J., Hwang A.B., Kenyon C. Inhibition of respiration extends C. elegans life span via reactive oxygen species that increase HIF-1 activity. Curr. Biol. 2010, 20:2131-2136. (2010/11/26 Ed.).
49. Veal E.A., Day A.M., Morgan B.A. Hydrogen peroxide sensing and signaling. Mol. Cell 2007, 26:1-14. (2007/04/17 Ed.).
50. Calabrese E.J., Bachmann K.A., Bailer A.J., Bolger P.M., Borak J., Cai L., Cedergreen N., Cherian M.G., Chiueh C.C., Clarkson T.W., Cook R.R., Diamond D.M., Doolittle D.J., Dorato M.A., Duke S.O., Feinendegen L., Gardner D.E., Hart R.W., Hastings K.L., Hayes A.W., Hoffmann G.R., Ives J.A., Jaworowski Z., Johnson T.E., Jonas W.B., Kaminski N.E., Keller J.G., Klaunig J.E., Knudsen T.B., Kozumbo W.J., et al. Biological stress response terminology: integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework. Toxicol. Appl. Pharmacol. 2007, 222:122-128.
51. Finn N.A., Kemp M.L. Pro-oxidant and antioxidant effects of N-acetylcysteine regulate doxorubicin-induced NF-kappa B activity in leukemic cells. Mol. Biosyst. 2012, 8:650-662.
52. Naviaux R.K. Oxidative shielding or oxidative stress?. J. Pharmacol. Exp. Ther. 2012, 342:608-618.
53. Medved I., Brown M.J., Bjorksten A.R., Murphy K.T., Petersen A.C., Sostaric S., Gong X., McKenna M.J. N-acetylcysteine enhances muscle cysteine and glutathione availability and attenuates fatigue during prolonged exercise in endurance-trained individuals. J. Appl. Physiol. 2004, 97:1477-1485.
54. Sadowska A.M., Manuel Y.K.B., De Backer W.A. Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review. Pulm. Pharmacol. Ther. 2007, 20:9-22. (2006/02/07 Ed.).
55. Gutteridge J.M.C., Halliwell B. Antioxidants: molecules, medicines, and myths. Biochem. Biophys. Res. Commun 2010, 393:561-564. Elsevier Inc.
56. Strobel N.A., Peake J.M., Matsumoto A., Marsh S.A., Coombes J.S., Wadley G.D. Antioxidant supplementation reduces skeletal muscle mitochondrial biogenesis. Med. Sci. Sports Exerc. 2011, 43:1017-1024.
57. Steinhubl S.R. Why have antioxidants failed in clinical trials?. Am. J. Cardiol. 2008, 101:14D-19D.
58. Downs J.R., Clearfield M., Weis S., Whitney E., Shapiro D.R., Beere P.A., Langendorfer A., Stein E.A., Kruyer W., Gotto A.M. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998, 279:1615-1622. (1998/06/05 Ed.).
59. Dam A.D., Mitchell A.S., Quadrilatero J. Induction of mitochondrial biogenesis protects against caspase-dependent and caspase-independent apoptosis in L6 myoblasts. Biochim. Biophys. Acta 2013, Elsevier B.V.